These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5787318)

  • 1. Long-term effects of clofibrate (Atromid-S) on serum lipids in man.
    Hunninghake DB; Tucker DR; Azarnoff DL
    Circulation; 1969 May; 39(5):675-83. PubMed ID: 5787318
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1974; 19(3):407-15. PubMed ID: 4364073
    [No Abstract]   [Full Text] [Related]  

  • 3. [Association of neomycin sulfate and ethyl-p-chlorophenoxybutyrate in the treatment of dyslipemia].
    Bertulla A; Bertamino V; Solari E
    Ateneo Parmense 1; 1971; 42(2):103-14. PubMed ID: 5154400
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action mechanism and clinical success of Regelan (Clofibrate)].
    Fitzgerald JD
    Wien Klin Wochenschr; 1967 Sep; 79(39):716-20. PubMed ID: 5595437
    [No Abstract]   [Full Text] [Related]  

  • 5. Atromid-S for the reduction of plasma lipids.
    Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633
    [No Abstract]   [Full Text] [Related]  

  • 6. Clofibrate and androsterone effect on serum lipids.
    Orgain ES; Bogdonoff MD; Cain C
    Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
    [No Abstract]   [Full Text] [Related]  

  • 7. The primary preventiono of ischemic heart disease by means of Atromid-S (clofibrate).
    Oliver MF
    Bull N Y Acad Med; 1968 Aug; 44(8):1021-7. PubMed ID: 4875747
    [No Abstract]   [Full Text] [Related]  

  • 8. Some clinical potentials of chlorophenoxyisobutyrate (clofibrate) therapy (hyperlipidemia--angina pectoris--blood sludging-diabetic neuropathy).
    Duncan GG; Elliott FA; Duncan TG; Schatanoff J
    Metabolism; 1968 May; 17(5):457-73. PubMed ID: 5648211
    [No Abstract]   [Full Text] [Related]  

  • 9. [Importance of the clofibrat in the treatment of lipid metabolism disorders].
    Laubinger G
    Med Klin; 1968 Jan; 63(4):139-42. PubMed ID: 5670163
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term therapy of adult cases of primary hypertriglyceridaemia with clofibrate (ethyl-p-chlorophenoxyisobutyrate).
    Braunsteiner H; Herbst M; Sandhofer F; Sailer S
    Ger Med Mon; 1968 Feb; 13(2):65-72. PubMed ID: 5653144
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral-contraceptive opposition to hypocholesterolaemic action of clofibrate.
    Smith RB; Prior IA
    Lancet; 1968 Apr; 1(7545):750-1. PubMed ID: 4170982
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of clofibrate on serum and hepatic lipids in nephrotic rats.
    Hoak JC; Connor WE; Armstrong ML; Warner ED
    Lab Invest; 1968 Oct; 19(4):370-5. PubMed ID: 5699117
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term treatment of hyperlipidemic patients with clofibrate.
    Berkowitz D
    JAMA; 1971 Nov; 218(7):1002-5. PubMed ID: 5000568
    [No Abstract]   [Full Text] [Related]  

  • 14. An effective treatment of hypercholesterolaemia using a combination of Secholex and clofibrate.
    Evans RJ; Howard AN; Hyams DE
    Angiology; 1973 Jan; 24(1):22-8. PubMed ID: 4694031
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trial with ethyl-a-p-chlorophenoxyisobutyrate (Atromid-S) with special reference to white blood cell counts.
    Engström J
    Acta Med Scand; 1966 Nov; 180(5):519-31. PubMed ID: 5332263
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N
    Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
    [No Abstract]   [Full Text] [Related]  

  • 17. REDUCTION OF SERUM TRIGLYCERIDES AND CHOLESTEROL BY ETHYL P-CHLOROPHENOXY-ISOBUTYRATE (CPIB).
    BEST MM; DUNCAN CH
    Am J Cardiol; 1965 Feb; 15():230-3. PubMed ID: 14254816
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of essential hyperlipidemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:184-7. PubMed ID: 4918619
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of long acting fluvastatin on parameters of lipid metabolism in patients with type 2 diabetes and combined hyperlipidemia].
    Kozlov SG; Liakishev AA; Titov VN; Naumov VG
    Kardiologiia; 2004; 44(10):60-3. PubMed ID: 15477793
    [No Abstract]   [Full Text] [Related]  

  • 20. A TWO-YEAR EVALUATION OF "ATROMID" FOR THE CONTROL OF ABNORMAL BLOOD LIPID LEVELS.
    PEAK HJ; MITCHELL AS; JOSE AD
    Med J Aust; 1965 Jul; 2(5):192-4. PubMed ID: 14348329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.